Pink Sheet Report Looks at Influence of NHS England, NICE

January 29, 2020

A recent analysis by The Pink Sheet dives into the influence of two drug pricing forces in the U.K.: the National Institute for Health and Care Excellence and NHS England.

To read The Pink Sheet’s analysis, click here. (Paid subscription required)

Share This Story!